
At Genomics England, our vision is a world where everyone benefits from genomic healthcare.
From the latest research to the lived experiences of those affected by rare conditions and cancer, Behind the Genes brings you closer to the people behind the science.
Each month, we release a deep-dive episode, alongside our Genomics 101 series - short explainers designed to make complex terms in genetics and genomics easier to understand.
At Genomics England, our vision is a world where everyone benefits from genomic healthcare.
From the latest research to the lived experiences of those affected by rare conditions and cancer, Behind the Genes brings you closer to the people behind the science.
Each month, we release a deep-dive episode, alongside our Genomics 101 series - short explainers designed to make complex terms in genetics and genomics easier to understand.
Episodes

Wednesday Apr 27, 2022
Cancer biology and the future of cancer research
Wednesday Apr 27, 2022
Wednesday Apr 27, 2022
“It's critical that the general public understand that science is a long process, and that science is a process that often begins with the art of the feasible. […] We wouldn't be anywhere without computers, we wouldn't be anywhere without DNA sequencing methods. That not only gives me confidence, but it also makes me feel that there's an awful lot left to do.”
In this week’s episode, our Chief Ecosystems and Partnership Officer Parker Moss is joined by Harold Varmus, who was previously the director of the National Institute of Health and of the National Cancer Institute and is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center. He also won the 1989 Nobel Prize in Physiology or Medicine for discovery of the cellular origin of retroviral oncogenes with J. Michael Bishop.
Today they discuss cancer biology, the future of cancer research and the major questions that studying diverse ethnicities will uncover through genomics. Harold and Parker also discussed some of the big challenges of bringing molecular diagnostics and genomics into lower income countries and the technologies that are continuing to help explore functional genomics in cancer.

No comments yet. Be the first to say something!